Any feedback?
Literature summary extracted from
- A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression (2008), Prim. Care Companion J. Clin. Psychiatry, 10, 25-30.
Application
| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 1.4.3.4 | medicine | selegiline is an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression. The selegiline transdermal system provides several advantages compared to orally administered monoamine oxidase inhibitors, including minimal interaction with dietary tyramine and prolonged exposure to the parent compound, while offering a favorable side effect profile. Treatment at the lowest effective dose of 6 mg/24 hours can be administered without the need for dietary modifications | Homo sapiens |
Inhibitors
| EC Number | Inhibitors | Comment | Organism | Structure |
|---|---|---|---|---|
| 1.4.3.4 | selegiline | an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression | Homo sapiens |  |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 1.4.3.4 | Homo sapiens | - |
- |
- |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
